Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism (2001)
Chapter: Appendix B: March 8, 2001 - Meeting Agenda
Page 75
APPENDIX B
March 8, 2001
Meeting Agenda
IMMUNIZATION SAFETY REVIEW COMMITTEE MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM MEETING
National Academies Building
2101 Constitution Ave., NW
Washington, D.C.
|
8:30–8:35 a.m. |
Opening Remarks Marie McCormick, M.D., Sc.D., Chair, Immunization Safety Review Committee |
|
8:35–9:00 a.m. |
Neurobiology and Neuropathology of Autism Thomas Kemper, M.D., Professor, Department of Neurology, Anatomy, and Pathology, Boston University School of Medicine |
|
9:00–9:30 a.m. |
Etiology of Autism and NIH Research Marie Bristol-Power, Ph.D., Special Assistant on Autism, Office of the Director, National Institute of Child Health and Human Development, National Institutes of Health |
Page 76
|
9:30–10:00 a.m. |
Diagnosis and Assessment of Autism Fred Volkmar, M.D., Professor of Child Psychiatry, Pediatrics, and Psychology, Yale Child Study Center |
|
10:15–10:45 a.m. |
Epidemiological Evidence on Rates of Autism and Time Trends Eric Fombonne, M.D., FRCPsych, Reader in Epidemiological Child Psychiatry, Institute of Psychiatry, King's College London |
|
10:45–11:00 a.m. |
Trends in Students with Autism in IDEA Programs Louis Danielson, Ph.D., Director of Research to Practice Division, Office of Special Education Programs, Department of Education |
|
11:00–11:45 a.m. |
Discussion Panel Kathryn Carbone, M.D., Chief, Laboratory of Pediatric and Respiratory Viral Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration Karin Nelson, M.D., Senior Investigator, Neuroepidemiology Branch, National Institute for Neurological Disorders and Stroke, National Institutes of Health Ezra Susser, M.D., Head, Division of Epidemiology, Joseph L. Mailman School of Public Health, Columbia University |
|
12:30–1:30 p.m. |
Hypothesis and Data Linking MMR, Bowel Symptoms and Autism Andrew Wakefield, M.D., Royal Free & University College Medical School, United Kingdom Kenneth Aitken, Ph.D., Independent Consultant Child Clinical Neuropsychologist |
|
1:30–2:00 p.m. |
Overview of Epidemiological Studies Examining Potential Link Between MMR, Bowel Symptoms, and Autism Michael Stoto, Ph.D., Chair, Department of Epidemiology and Biostatistics, George Washington University |
|
2:00–2:30 p.m. |
New Data and Research Findings Regarding a Potential Link Between MMR, Bowel Symptoms, and Autism |
Page 77
Eric Fombonne, M.D., FRCPsych, Reader in Epidemiological Child Psychiatry, Institute of Psychiatry, King's College London |
2:45–4:00 p.m.
Discussion Panel
Scott Montgomery, Ph.D., Karolinska Institute, Sweden
Brian Ward, M.D., Associate Professor, Medicine & Microbiology, McGill University and Montreal General Hospital Research Institute
Michael Gershon, M.D., Professor and Chair, Department of Anatomy and Cell Biology, Columbia University
Kathryn Carbone, M.D., Chief, Laboratory of Pediatric and Respiratory Viral Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration
Karin Nelson, M.D., Senior Investigator, Neuroepidemiology Branch, National Institute for Neurological Disorders and Stroke, National Institutes of Health
4:00–4:15 p.m.
Study of Autism and the Vaccine Adverse Event Reporting System (VAERS)
Jane Woo, M.D., M.P.H., Fellow, Vaccine Safety Branch, Division of Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration
4:15–5:00 p.m.
Public Comment Session
